Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.88 USD | -2.13% | +0.19% | +3.22% |
Business Summary
Number of employees: 197
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 464 | 100.0 % | 567 | 100.0 % | +22.17% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 464 | 100.0 % | 567 | 100.0 % | +22.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 01-12-31 | |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 21-05-23 |
Scott Sudduth
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Shirley Kuhlmann
ADM | Chief Administrative Officer | 40 | 18-03-15 |
Thomas Smith
CTO | Chief Tech/Sci/R&D Officer | 63 | 22-03-22 |
Investor Relations Contact | - | 22-12-31 | |
Kelly Clements
HRO | Human Resources Officer | - | 22-04-30 |
Scott Dreyer
PRN | Corporate Officer/Principal | 52 | 17-12-31 |
Arun Padmanabhan
SAM | Sales & Marketing | - | 17-09-30 |
Bart J. Dunn
PRN | Corporate Officer/Principal | 65 | 19-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 14-12-31 |
Gino Santini
BRD | Director/Board Member | 67 | 12-07-23 |
John Freund
BRD | Director/Board Member | 70 | 14-01-31 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 17-08-08 |
Chief Executive Officer | 59 | 01-12-31 | |
John Fallon
BRD | Director/Board Member | 76 | 16-06-12 |
Neil McFarlane
BRD | Director/Board Member | 51 | 22-04-05 |
Director/Board Member | 63 | 20-09-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 39,039,214 | 32,226,217 ( 82.55 %) | 6,323,892 ( 16.20 %) | 82.55 % |
Company contact information
Collegium Pharmaceutical, Inc.
100 Technology Center Drive Suite 300
02072, Stoughton
+781 713 3699
http://www.collegiumpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.40% | 1.07B | |
+47.57% | 780B | |
+41.50% | 627B | |
+20.31% | 334B | |
+7.30% | 296B | |
+17.23% | 244B | |
-0.86% | 217B | |
+11.55% | 214B | |
+5.23% | 161B | |
-3.44% | 159B |
- Stock Market
- Equities
- COLL Stock
- Company Collegium Pharmaceutical, Inc.